Yifang Biotechnology: It is estimated that the net loss in 2025 will be 292 million yuan.

Yifang Biotechnology announced that it is expected to have a net loss of 292 million yuan attributable to the owners of the parent company in 2025. The company achieved operating income of 37.2452 million yuan in 2025 and is expected to continue to incur losses. The performance of the company in 2025 is mainly affected by the intensity of research and development investment and the composition of revenue.